Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Lenalidomide promotes the development of TP53 -mutated therapy-related myeloid neoplasms

Blood (2022) 140 (16): 1753–1763.

https://doi.org/10.1182/blood.2021014956

Published: 2022

Includes: Supplemental data

Journal Articles

Clonal dynamics and clinical implications of postremission clonal hematopoiesis in acute myeloid leukemia

Blood (2021) 138 (18): 1733–1739.

https://doi.org/10.1182/blood.2020010483

Published: 2021

Includes: Supplemental data

Journal Articles

Prognostic Significance of Genetic Alterations in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Treated with Hyper-CVAD Plus Dasatinib or Hyper-CVAD Plus Ponatinib

Yuya Sasaki, MDPhD, Hagop M. Kantarjian, MD, Nicholas J. Short, MD, Nitin Jain, MD, Koji Sasaki, MD, Farhad Ravandi, MBBS, Marina Konopleva, MD PhD, Guillermo Garcia-Manero, MD, Latasha Little, BS, Curtis Gumbs, Li Zhao, PhD, P Andrew Futreal, PhD, Feng Wang, PhD, Ken Furudate, DDM, PhD, Rebecca Garris, MSc, Koichi Takahashi, MD PhD, Elias Jabbour, MD

Blood (2020) 136 (Supplement 1): 40–41.

https://doi.org/10.1182/blood-2020-136676

Published: 2020

Journal Articles

Extensive Changes of the Immune Microenvironment Are Associated with Progression from Precursor Stages to Multiple Myeloma

Blood (2020) 136 (Supplement 1): 37–38.

https://doi.org/10.1182/blood-2020-137555

Published: 2020

Journal Articles

Single-Cell Characterization of Acute Myeloid Leukemia (AML) and Its Microenvironment Identifies Signatures of Resistance to PD-1 Blockade Based Therapy

Blood (2020) 136 (Supplement 1): 29–31.

https://doi.org/10.1182/blood-2020-137335

Published: 2020

Journal Articles

Immunologic Predictors for Clinical Responses in Patients with Myelodysplastic Syndromes Treated with Immune Checkpoint Blockade

Sung-Eun Lee, MD PhD, Feng Wang, PhD, Abel Trujillo-Ocampo, PhDMS, Wilfredo Ruiz Vazquez, Hyun-Woo Cho, Koichi Takahashi, MD PhD, Gheath Alatrash, Jeffrey J. Molldrem, Richard E. Champlin, MD, Naval Daver, MD, Hagop M. Kantarjian, MD, P. Andrew Futreal, Guillermo Garcia-Manero, MD, Jin S. Im

Blood (2020) 136 (Supplement 1): 4.

https://doi.org/10.1182/blood-2020-136963

Published: 2020

Journal Articles

Characterization of Changes in the T-Cell Receptor Repertoire in Patients with Acute Myeloid Leukemia with Durable Remission Following Allogeneic Stem Cell Transplant

Ronald M. Paranal, MD, Hagop M. Kantarjian, MD, Alexandre Reuben, PhD, Celine Kerros, PhD, Priya Koppikar, PhD, Latasha Little, BS, Curtis Gumbs, Nicholas J. Short, MD, Jorge E. Cortes, MD, Elias Jabbour, MD, Jeffrey J. Molldrem, P. Andrew Futreal, PhD, Ghayas C. Issa, MD

Blood (2019) 134 (Supplement_1): 5186.

https://doi.org/10.1182/blood-2019-129911

Published: 2019

Journal Articles

Prognostic Significance of IKZF1 , PAX5 , and CDKN2A Deletions in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Treated with Hyper-CVAD/MA with Dasatinib or Ponatinib

Yuya Sasaki, MD PhD, Nicholas J. Short, MD, Hagop M. Kantarjian, MD, Rebecca Garris, MSc, Nitin Jain, MD, Koji Sasaki, MD, Farhad Ravandi, MD, Marina Y Konopleva, MD PhD, Michael E. Rytting, MD, Guillermo Garcia-Manero, MD, Latasha Little, BS, Curtis Gumbs, Li Zhao, PhD, P. Andrew Futreal, PhD, Feng Wang, PhD, Koichi Takahashi, MD, Elias Jabbour, MD

Blood (2019) 134 (Supplement_1): 2753.

https://doi.org/10.1182/blood-2019-122017

Published: 2019

Journal Articles

Identification of Gene Expression Signatures in Leukemia Stem Cells and Minimal Residual Disease Following Treatment of Adverse Risk Acute Myeloid Leukemia

Ghayas C. Issa, MD, Christopher B. Benton, MD, Vakul Mohanty, PhD, Yifei Shen, PhD, Zoe Alaniz, Feng Wang, PhD, P. Andrew Futreal, PhD, Wei Wang, MD PhD, Jeffrey L. Jorgensen, MD PhD, Nicholas Navin, PhD, Marina Y Konopleva, MD PhD, Ken Chen, PhD, Michael Andreeff, MD PhD

Blood (2019) 134 (Supplement_1): 2717.

https://doi.org/10.1182/blood-2019-130540

Published: 2019

Journal Articles

Clonal Dynamics and Clinical Implications of Post-Remission Clonal Hematopoiesis in Acute Myeloid Leukemia (AML)

Tomoyuki Tanaka, Kiyomi Morita, MD, Feng Wang, PhD, Latasha Little, Curtis Gumbs, Jairo Matthews, Courtney D. DiNardo, MDMSc, Tapan M. Kadia, MD, Farhad Ravandi, MD, Marina Y Konopleva, MD PhD, Hagop M. Kantarjian, MD, Richard E. Champlin, MD, Guillermo Garcia-Manero, MD, P Andrew Futreal, PhD, Koichi Takahashi, MD

Blood (2019) 134 (Supplement_1): 17.

https://doi.org/10.1182/blood-2019-122274

Published: 2019

Journal Articles

PRDM16s transforms megakaryocyte-erythroid progenitors into myeloid leukemia–initiating cells

Tianyuan Hu, Kiyomi Morita, Matthew C. Hill, Yajian Jiang, Ayumi Kitano, Yusuke Saito, Feng Wang, Xizeng Mao, Kevin A. Hoegenauer, Kazuhiro Morishita, James F. Martin, P. Andrew Futreal, Koichi Takahashi, Daisuke Nakada

Blood (2019) 134 (7): 614–625.

https://doi.org/10.1182/blood.2018888255

Published: 2019

Includes: Supplemental data

Journal Articles

Pan-Myeloid Leukemia Analysis: Machine Learning-Based Approach to Predict Phenotype and Clinical Outcomes Using Mutation Data

Blood (2018) 132 (Supplement 1): 1801.

https://doi.org/10.1182/blood-2018-99-116685

Published: 2018

Journal Articles

Single-Cell Atlas of Driver Mutations in Acute Myeloid Leukemia (AML)

Blood (2018) 132 (Supplement 1): 88.

https://doi.org/10.1182/blood-2018-99-117358

Published: 2018

Journal Articles

Clinical implications of cancer gene mutations in patients with chronic lymphocytic leukemia treated with lenalidomide

Blood (2018) 131 (16): 1820–1832.

https://doi.org/10.1182/blood-2017-11-817296

Published: 2018

Includes: Supplemental data

Journal Articles

Differential and Limited Expression of Mutant Alleles in Multiple Myeloma

Adam Sperling, MD PhD, Naim Rashid, PhD, Niccolo Bolli, MD PhD, David Wedge, PhD, Peter Van Loo, PhD, Yu-Tzu Tai, Masood Shammas, PhD, Mariateresa Fulciniti, PhD, Mehmet Kemal Samur, PhD, Paul G. Richardson, Florence Magrangeas, Stephane Minvielle, P Andrew Futreal, Kenneth C. Anderson, Herve Avet-loiseau, Peter J. Campbell, PhD, Giovanni Parmigiani, PhD, Nikhil Munshi

Blood (2014) 124 (21): 2007.

https://doi.org/10.1182/blood.V124.21.2007.2007

Published: 2014

Journal Articles

Differential and limited expression of mutant alleles in multiple myeloma

Naim U. Rashid, Adam S. Sperling, Niccolo Bolli, David C. Wedge, Peter Van Loo, Yu-Tzu Tai, Masood A. Shammas, Mariateresa Fulciniti, Mehmet K. Samur, Paul G. Richardson, Florence Magrangeas, Stephane Minvielle, P. Andrew Futreal, Kenneth C. Anderson, Herve Avet-Loiseau, Peter J. Campbell, Giovanni Parmigiani, Nikhil C. Munshi

Blood (2014) 124 (20): 3110–3117.

https://doi.org/10.1182/blood-2014-04-569327

Published: 2014

Includes: Supplemental data

Journal Articles

Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms

Blood (2011) 118 (24): 6239–6246.

https://doi.org/10.1182/blood-2011-09-377275

Published: 2011

Includes: Supplemental data

Journal Articles

The Genomic Landscape of TEL-AML1 + ( ETV6-RUNX1 ) Acute Lymphoblastic Leukaemia

Elli Papaemmanuil, Inmaculada Rapado, Anthony M Ford, Keiran Raine, Jonathan Hinton, David Jones, John Marshall, Laura J Mudie, Jan Zuna, Giovanni Cazzaniga, Helena Kempski, Maria S Pombo de Oliveira, Mike R Stratton, P Andrew Futreal, Peter Campbell, Mel Greaves

Blood (2011) 118 (21): 403.

https://doi.org/10.1182/blood.V118.21.403.403

Published: 2011

Journal Articles

Somatic Mutation of SF3B1 , a Gene Encoding a Core Component of RNA Splicing Machinery, in Myelodysplasia with Ring Sideroblasts

Blood (2011) 118 (21): 3.

https://doi.org/10.1182/blood.V118.21.3.3

Published: 2011

Journal Articles

The V617F JAK2 mutation is uncommon in cancers and in myeloid malignancies other than the classic myeloproliferative disorders

Linda M. Scott, Peter J. Campbell, E. Joanna Baxter, Tony Todd, Philip Stephens, Sarah Edkins, Richard Wooster, Michael R. Stratton, P. Andrew Futreal, Anthony R. Green

Blood (2005) 106 (8): 2920–2921.

https://doi.org/10.1182/blood-2005-05-2087

Published: 2005

NARROW

Lenalidomide promotes the development of TP53 -mutated therapy-related myeloid neoplasms

Clonal dynamics and clinical implications of postremission clonal hematopoiesis in acute myeloid leukemia

Prognostic Significance of Genetic Alterations in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Treated with Hyper-CVAD Plus Dasatinib or Hyper-CVAD Plus Ponatinib

Extensive Changes of the Immune Microenvironment Are Associated with Progression from Precursor Stages to Multiple Myeloma

Single-Cell Characterization of Acute Myeloid Leukemia (AML) and Its Microenvironment Identifies Signatures of Resistance to PD-1 Blockade Based Therapy

Immunologic Predictors for Clinical Responses in Patients with Myelodysplastic Syndromes Treated with Immune Checkpoint Blockade

Characterization of Changes in the T-Cell Receptor Repertoire in Patients with Acute Myeloid Leukemia with Durable Remission Following Allogeneic Stem Cell Transplant

Prognostic Significance of IKZF1 , PAX5 , and CDKN2A Deletions in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Treated with Hyper-CVAD/MA with Dasatinib or Ponatinib

Identification of Gene Expression Signatures in Leukemia Stem Cells and Minimal Residual Disease Following Treatment of Adverse Risk Acute Myeloid Leukemia

Clonal Dynamics and Clinical Implications of Post-Remission Clonal Hematopoiesis in Acute Myeloid Leukemia (AML)

PRDM16s transforms megakaryocyte-erythroid progenitors into myeloid leukemia–initiating cells

Pan-Myeloid Leukemia Analysis: Machine Learning-Based Approach to Predict Phenotype and Clinical Outcomes Using Mutation Data

Single-Cell Atlas of Driver Mutations in Acute Myeloid Leukemia (AML)

Clinical implications of cancer gene mutations in patients with chronic lymphocytic leukemia treated with lenalidomide

Differential and Limited Expression of Mutant Alleles in Multiple Myeloma

Differential and limited expression of mutant alleles in multiple myeloma

Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms

The Genomic Landscape of TEL-AML1 + ( ETV6-RUNX1 ) Acute Lymphoblastic Leukaemia

Somatic Mutation of SF3B1 , a Gene Encoding a Core Component of RNA Splicing Machinery, in Myelodysplasia with Ring Sideroblasts

The V617F JAK2 mutation is uncommon in cancers and in myeloid malignancies other than the classic myeloproliferative disorders

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only